Analytical techniques for the determination of verapamil in biological samples and dosage forms: an overview.
Fariba PourkarimElaheh RahimpourAbolghasem JouybanPublished in: Bioanalysis (2019)
Verapamil (VER) is a calcium channel blocker that is widely used to treat various cardiovascular diseases and is also effective in migraine prophylaxis. As the therapeutic range of VER is very narrow and toxicity can occur in patients after oral administration, therapeutic drug monitoring is recommended to optimize pharmacotherapy. The choice of an appropriate bioanalytical method for therapeutic drug monitoring of VER in the biological samples is a very important step in achieving fast and reliable results. This review focuses on the various analytical methods reported between 1976 and 2019 for the determination of VER in different biological samples and pharmaceutical dosage forms along with their methodological limitations. This review provides an overview for pharmaceutical industry researchers, clinicians and clinical chemists.
Keyphrases
- end stage renal disease
- cardiovascular disease
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- palliative care
- prognostic factors
- molecularly imprinted
- type diabetes
- liquid chromatography
- patient reported outcomes
- metabolic syndrome
- mass spectrometry
- high resolution
- angiotensin converting enzyme
- angiotensin ii